CG
FENC icon

Cutler Group’s Fennec Pharmaceuticals FENC Stock Holding History

Cutler Group’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-139
Closed -$1K – 4630
2022
Q3 		$1K Buy
+139
New +$954 ﹤0.01% 4519
2021
Q3 		– Sell
-100
Closed – – 5888
2021
Q2 		$0 Sell
100
-100
-50% -$667 ﹤0.01% 5876
2021
Q1 		$1K Buy
200
+100
+100% +$753 ﹤0.01% 5203
2020
Q4 		$0 Hold
100
– – ﹤0.01% 5003
2020
Q3 		$0 Sell
100
-700
-88% -$4.93K ﹤0.01% 4836
2020
Q2 		$6K Buy
+800
New +$5.95K ﹤0.01% 3184

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Cutler Group's FENC Position: Q4 2022 in Review

Cutler Group sold out of Fennec Pharmaceuticals (FENC) in Q4 2022, closing a stake of 139 shares — an estimated $1K sold.

Cutler Group first reported a position in FENC in Q2 2020 and held it in 6 quarters. The position peaked at $6K in Q2 2020. 43 funds tracked by Wall St. Rank hold FENC as of Q4 2022.

  • Cutler Group reported no remaining Fennec Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 139 Fennec Pharmaceuticals shares in Q4 2022, an estimated $1K.
  • Cutler Group first reported a position in Fennec Pharmaceuticals in Q2 2020 and held it in 6 quarters.
  • Cutler Group's Fennec Pharmaceuticals position peaked at $6K in Q2 2020.
  • 43 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.